- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on High Risk Superficial Upper Urinary Tract Transitional Cell Carcinoma
Total 3156 results
-
European Organisation for Research and Treatment...National Cancer Institute (NCI); NCIC Clinical Trials Group; Institute of Cancer... and other collaboratorsCompletedStage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder
-
Endo PharmaceuticalsTerminatedCarcinoma in Situ | Transitional Cell Carcinoma | Non-muscle Invasive Bladder CancerUnited States
-
National Cancer Institute (NCI)TerminatedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Transitional Cell Carcinoma of the Bladder | Localized Transitional Cell Cancer of the...United States
-
Association Pour La Recherche des Thérapeutiques...Roche Pharma AGCompletedRecurrent Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the BladderFrance, Belgium
-
Emory UniversityTerminatedBladder Cancer | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Squamous Cell Carcinoma of the BladderUnited States
-
Cadila PharnmaceuticalsCompleted
-
Eli Lilly and CompanyCompletedUrologic NeoplasmsFinland, France, Germany
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedUpper Tract Urothelial Carcinomas | Urothelial Bladder CancerUnited States, France, Canada, Spain, Italy, Belgium, Germany, Netherlands, United Kingdom, Bulgaria, Greece
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Seromucinous Carcinoma | Recurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Fallopian Tube Mucinous Adenocarcinoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent... and other conditionsUnited States, Puerto Rico
-
Peking University First HospitalUnknownRecurrence | Metastasis | Upper Tract Urothelial Carcinoma | Lymph Node DissectionChina
-
Five Prime Therapeutics, Inc.CompletedGastric Cancer | Advanced Solid Tumors | Transitional Cell Carcinoma of the BladderKorea, Republic of, United States, Taiwan
-
Tulane University Health Sciences CenterCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
University Teaching Hospital Hall in TirolSalzburger LandesklinikenRecruitingNeoplasms | Urogenital Neoplasms | Transitional Cell Carcinoma | Circulating Tumor Cell | Urinary Bladder NeoplasmAustria
-
Eli Lilly and CompanyCompletedUrologic Neoplasms | Carcinoma, Transitional CellJapan
-
Matthew GalskyNovartis Pharmaceuticals; Hoosier Cancer Research NetworkTerminatedTransitional Cell Carcinoma | Urothelial Carcinoma | Bladder CarcinomaUnited States
-
RenJi HospitalPeking University First Hospital; Xiangya Hospital of Central South University and other collaboratorsRecruitingMuscle Invasive Upper Tract Urothelial CarcinomaChina
-
Clinique Beau SoleilCepheid; Team Languedoc Mutualité / Nouvelles technologiesCompletedNon-Invasive Bladder Urothelial Carcinoma | Non-Invasive Bladder Papillary Urothelial Carcinoma, Low Grade | Non-Invasive Bladder Papillary Urothelial Carcinoma, High GradeFrance
-
Seth LernerAstraZeneca; Cytogen CorporationCompletedUrinary Bladder NeoplasmsUnited States, Italy
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Mark Pomerantz, MDMerck Sharp & Dohme LLC; Rainier TherapeuticsTerminatedBladder CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedTransitional Cell Carcinoma | Bladder CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Acrotech Biopharma Inc.CompletedCarcinoma, Transitional Cell | Bladder Cancer | Bladder NeoplasmSpain, France, Belgium, United States, Argentina, Croatia
-
Queen Mary University of LondonNot yet recruitingTransitional Cell Carcinoma | Bladder Cancer
-
Queen Mary University of LondonHoffmann-La RocheUnknownBladder CancerUnited Kingdom, France, Spain, Netherlands
-
Merck Sharp & Dohme LLCCompleted
-
National Cancer Institute (NCI)CompletedCarcinoma, Transitional Cell | Bladder NeoplasmsUnited States
-
AmgenUnknownBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Institut CurieCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterFrance
-
National Cancer Institute (NCI)CompletedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Squamous Cell Carcinoma of the BladderUnited States
-
National Cancer Institute (NCI)CompletedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional...Canada
-
M.D. Anderson Cancer CenterCompletedBladder CancerUnited States
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedTransitional Cell Carcinoma | Bladder CancerItaly
-
University of British ColumbiaCanadian Urologic Oncology GroupCompletedTransitional Cell Carcinoma | Bladder CancerCanada
-
University of Southern CaliforniaNational Cancer Institute (NCI); GlaxoSmithKlineTerminatedRecurrent Bladder Cancer | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the BladderUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Hull University Teaching Hospitals NHS TrustC-Term Diagnostics Ltd; Hull York Medical SchoolCompletedTransitional Cell CarcinomaUnited Kingdom
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnTransitional Cell Carcinoma | Infiltrating Bladder Urothelial Carcinoma | Stage II Bladder Urothelial Carcinoma
-
National Cancer Institute (NCI)CompletedRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Transitional Cell Carcinoma of the Bladder | Ureter Cancer | Recurrent Urethral CancerUnited States
-
King Faisal Specialist Hospital & Research CenterCompleted
-
University of MichiganCompletedUrinary Tract Urothelial CarcinomaUnited States
-
QH Medical Technology Ltd.Not yet recruiting
-
National Cancer Institute (NCI)RecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Fallopian Tube Transitional Cell Carcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Fallopian Tube Clear... and other conditionsUnited States
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Recruiting
-
Bristol-Myers SquibbCompletedTransitional Cell Carcinoma | Bladder Cancer | MetastasisUnited States, Korea, Republic of, United Kingdom, Spain, Australia, France, Thailand, Denmark, Poland, Belgium, Italy, Philippines, Canada, Russian Federation, Greece, Indonesia
-
Cardiff UniversityCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited Kingdom
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral Cancer
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral Cancer